Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU First Update
The Surviving Sepsis Campaign (SSC) has updated the previously released Guidelines on the Management of Critically Ill Adults With Coronavirus Disease...
SCCM Supports FCCS Training in Tajikistan
Khorog, the regional capital of Gorno-Badakhshan Autonomous Oblast (GBAO), sits at an elevation of 2200 meters among the beautiful but rugged and isol...
Critical Care and Pulmonary Societies Encourage Flu Shots Amid COVID-19 Spread
The members of the Critical Care Societies Collaborative, which are the American Association of Critical-Care Nurses (AACN), American College of Chest...
Ethical Considerations for a COVID-19 Vaccine Mandate
Mandate to vaccinate or nudge if there is no budge? COVID-19 vaccines remain a key weapon in the fight against the deadliest modern-day pandemic the w...
An SCCM Member Responds to a Call for Volunteers
Before the COVID-19 pandemic, Tina R. Shah, MD, MPH, focused her work on two questions: How can technology help improve the United States health syste...
Johnson & Johnson’s Janssen COVID-19 Vaccine: What Clinicians Need to Know
In the past few weeks more than 7 million doses of Johnson & Johnson’s Janssen COVID-19 vaccine have been administered to people in the Unit...
Concise Critical Appraisal: Surviving Sepsis Campaign COVID-19 Guidelines Update
The updated Surviving Sepsis Campaign (SSC) COVID-19 guidelines are now available, reflecting the learnings from the latest major studies. This month&...
SCCM Pod-504 CCM: Baricitinib or Tocilizumab for Severe COVID-19
Host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Joy Peterson, PharmD, BCPS, BCIDP, and Neha Paranjape, MD, MPH, to discuss the Critical ...
SCCM Pod-496: Moving From Surviving to Thriving With Long COVID
Millions of people have long COVID and may experience cognitive, mental health, and physical side effects. Elizabeth H. Mack, MD, MS, FCCM, is joined ...
SCCM Pod-492: The Long and Short of Long COVID
COVID-19 survivors who experience severe critical illness are at risk even when they leave the ICU. Long COVID is becoming recognized as a widespread ...
SCCM Pod-491: Nursing the Wounds of Burnout
COVID-19 transformed healthcare and presented specific long-term challenges for the nursing profession. Samantha Gambles Farr, MSN, NP-C, CCRN, RNFA, ...
SCCM Pod-477: Going Viral With the Discovery VIRUS COVID-19 Registry
The Viral Infection and Respiratory Illness Universal Study (VIRUS) is a prospective, cross-sectional, observational study and registry of all eligibl...
SCCM Pod-463 CCM: Clazakizumab for COVID-19: Friend or Foe?
Clazakizumab is a monoclonal antibody against human interleukin-6 that may benefit patients hospitalized with severe or critical COVID-19 accompanied ...
SCCM Pod-434 Tracheostomy Adaptation for COVID-19 Patients
COVID-19 complicated critical care clinicians’ decision-making with regard to tracheostomy. ICU resource constraints and risk of staff exposure ...
SCCM Pod-441 Connections Between COVID-19, Sepsis, and Fluid Management
Learn about the importance of utilizing dynamic assessments of fluid responsiveness to guide treatment in patients with viral sepsis, i...
SCCM Pod-453 Extracorporeal Blood Purification
Because COVID-19 can create a status of systemic inflammation, which can affect multiple organs, including the kidneys, the adjuvant therapy of blood ...